Results 1 to 10 of about 50 (47)
Journal of Econometrics, 2023 Accepted for publication in Journal of ...
Jonathan Berrisch, Florian Ziel
openaire +5 more sources
CRP or not CRP? That Is the Question [PDF]
Arteriosclerosis, Thrombosis, and Vascular Biology, 2005 C-reactive protein (CRP) and cardiovascular disease is a very hot topic at present. Excitement and interest have spilled over dramatically from the scientific literature into the media and popular press leading to much speculative comment. However, rigorously controlled and reproducible studies are now laying the basis for a more realistic consensus ...
openaire +1 more source
Acute Coronary Syndromes: To CRP or Not to CRP?
Journal of the American College of Cardiology, 2008 We read with interest the article by Bogaty et al. ([1][1]), in which the authors failed to find an independent association between C-reactive protein (CRP) and outcome in a large, unselected population of patients presenting an acute coronary syndrome (ACS).
Biasucci, Luigi M. +2 more
openaire +1 more source
Effect of CRP and Kinetics of CRP in Prognosis of Nasopharyngeal Carcinoma [PDF]
Frontiers in Oncology, 2019 Baseline C-reactive protein (CRP) has been determined as a prognostic factor in nasopharyngeal carcinoma (NPC). This study was designed to further evaluate the impact of CRP kinetics on NPC patients. Thousand three hundred and seventy eight NPC patients from February 2001 to June 2011 were retrospectively reviewed.
Ruiwan Chen +6 more
openaire +3 more sources
Pain, 2008 CRPS-I is diagnosed on the basis of the patient’s signs and symptoms [4]. Of course, the cardinal symptom is the patient’s report of pain and the subjective nature of this report plus our inability to find objective evidence for any cause of the pain has led to many decades of debate and frustration. But things are changing.
Terence J, Coderre, Gary J, Bennett
openaire +2 more sources
Molecular Immunology, 2005 C-reactive protein (CRP) that has been conserved throughout evolution is a host-defense molecule. Its attraction towards phosphocholine-ligands, such as modified low-density lipoprotein, and apoptotic cells leads to the "masking" of these substances that have the capabilities to otherwise engage in deleterious activities.
openaire +3 more sources
CRP as a Mediator of Disease [PDF]
Circulation, 2004 Of the various hypotheses offered to explain atherosclerosis, inflammation now appears to provide a key to this pathological process. Inflammation has been shown to play a major role in precipitating a cascade of events from formation of the atheromatous lesion in response to vascular injury through lipid ingestion by macrophages, to subsequent rupture
openaire +2 more sources
Blood, 2015 In this issue of Blood, Kapur et al identify the acute-phase protein C-reactive protein (CRP), a general biomarker for infection and inflammation, as a potent mediator of antibody-dependent transfusion-related acute lung injury (TRALI). This study provides a novel and direct link between inflammation and TRALI, opening doors for possible new approaches
openaire +2 more sources
Journal of Clinical Investigation, 2004 The data will be what the data will be — regardless of a community’s fondest wishes. And the latest data from the most comprehensive epidemiological study carried out so far on C-reactive protein (CRP) and its predictive value for coronary heart disease (CHD) in the general population indicate that CRP is not as strong a predictor of heart disease ...
openaire +2 more sources
Neuroscience & Biobehavioral ReviewsFor complex regional pain syndrome (CRPS), a number of brain biomarkers have been identified which show overlaps but also unique characteristics to other chronic pain syndromes. We here provide a review about possible brain biomarkers for CRPS and differentiate their role for A) diagnosis of CRPS, B) monitoring of time course of CRPS (e.g., during ...
Martin Lotze, Sebastian Strauss
openaire +2 more sources